- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
PDGFRA predesign siRNASynthetic RNA
| Country | United States
Ordering Information
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| RI13882 | 5 OD 400 ul | 13-15 days | $ 110.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
PDGFRA predesign siRNA - Additional info | |
| Gene ID | 5156 |
| Gene Symbol | PDGFRA |
| Other Names CD140A, PDGFR2, MGC74795, RHEPDGFRA, PDGFRA | |
| Format HPLC purified siRNA is supplied as a dried pellet in nmol quantities. | |
| Storage Maintain refrigerated at 2-8°C for up to one week. For long term storage store at -20°C. | |
| Precautions This product is for research use only. Not for use in diagnostic or therapeutic procedures. | |
PDGFRA predesign siRNA - Related products
AP3329a: Phospho-PDGFRA-Y574 Antibody
AP3330a: Phospho-PDGFRA-Y762 Antibody
AP3331a: Phospho-PDGFRA-Y1018 Antibody
AP3410a: Phospho-PDGFRA-pY754 Antibody
AP3412a: Phospho-PDGFRA-pY988 Antibody
AP3506a: Phospho-PDGFRA-pY572 Antibody
AP7666b: PDGFRA Antibody (C-term E1063)
AP7666d: PDGFRA Antibody (Y720)
AP7666f: PDGFRA Antibody (Y762)
AP7666g: PDGFRA Antibody (S767)
AP7666h: PDGFRA Antibody (Y768)
AP7666i: PDGFRA Antibody (Y574)
AP7666j: PDGFRA Antibody (Y754)
AP7666k: PDGFRA Antibody (Y988)
AP7666l: PDGFRA Antibody (Y1018)
AP7666m: PDGFRA Antibody (Y572)
RI13882: PDGFRA predesign siRNA
DC04038: Human PDGFRA cDNA Clone
LY10723a: PDGFRA Over-expression Lysate
BP3329a: Phospho-PDGFRA-Y574 Antibody Blocking Peptide
BP3330a: Phospho-PDGFRA-Y762 Antibody Blocking Peptide
BP3331a: Phospho-PDGFRA-Y1018 Antibody Blocking Peptide
BP3410a: Phospho-PDGFRA-pY754 Antibody Blocking Peptide
BP3412a: Phospho-PDGFRA-pY988 Antibody Blocking Peptide
BP3506a: Phospho-PDGFRA-pY572 Antibody Blocking Peptide
BP7666b: PDGFRA Antibody (C-term E1063) Blocking Peptide
BP7666d: PDGFRA Antibody (Y720) Blocking Peptide
BP7666f: PDGFRA Antibody (Y762) Blocking Peptide
BP7666g: PDGFRA Antibody (S767) Blocking Peptide
BP7666h: PDGFRA Antibody (Y768) Blocking Peptide
BP7666i: PDGFRA Antibody (Y574) Blocking Peptide
BP7666j: PDGFRA Antibody (Y754) Blocking Peptide
BP7666k: PDGFRA Antibody (Y988) Blocking Peptide
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies in knockout mice, where homozygosity is lethal, indicate that the alpha form of the platelet-derived growth factor receptor is particularly important for kidney development since mice heterozygous for the receptor exhibit defective kidney phenotypes.
REFERENCES
Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors. Merkelbach-Bruse S, et al. BMC Med Genet, 2010 Jul 4. PMID 20598160. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. Paugh BS, et al. J Clin Oncol, 2010 Jun 20. PMID 20479398. Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors. Silva M, et al. BMC Med, 2010 May 14. PMID 20470368. A Large-scale genetic association study of esophageal adenocarcinoma risk. Liu CY, et al. Carcinogenesis, 2010 Jul. PMID 20453000. The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms. Russell MR, et al. Cancer Res, 2010 May 15. PMID 20442296.